SC

Stempoint Capital Portfolio holdings

AUM $311M
1-Year Est. Return 15.22%
This Quarter Est. Return
1 Year Est. Return
+15.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$313M
AUM Growth
-$85.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
79
New
Increased
Reduced
Closed

Top Buys

1 +$18M
2 +$13.6M
3 +$12.9M
4
BBIO icon
BridgeBio Pharma
BBIO
+$7.21M
5
CGON icon
CG Oncology
CGON
+$7.1M

Top Sells

1 +$16.2M
2 +$15.7M
3 +$13.4M
4
MRUS icon
Merus
MRUS
+$11.3M
5
PRAX icon
Praxis Precision Medicines
PRAX
+$10.3M

Sector Composition

1 Healthcare 99.51%
2 Financials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROIV icon
1
Roivant Sciences
ROIV
$11.8B
$26M 8.29%
2,578,860
-133,918
SNDX icon
2
Syndax Pharmaceuticals
SNDX
$1.23B
$19.6M 6.26%
1,598,594
-1,274,007
SRRK icon
3
Scholar Rock
SRRK
$2.69B
$18.2M 5.8%
566,212
+399,905
ACLX icon
4
Arcellx
ACLX
$4.82B
$18M 5.73%
+273,774
MRUS icon
5
Merus
MRUS
$7.19B
$14.6M 4.65%
346,756
-268,056
IMVT icon
6
Immunovant
IMVT
$3.05B
$14.6M 4.65%
853,472
-265,036
MDGL icon
7
Madrigal Pharmaceuticals
MDGL
$9.78B
$13.6M 4.32%
+40,936
NUVL icon
8
Nuvalent
NUVL
$6.67B
$13.5M 4.3%
190,401
+45,167
RVMD icon
9
Revolution Medicines
RVMD
$10.1B
$11.3M 3.59%
318,782
+125,247
JANX icon
10
Janux Therapeutics
JANX
$1.61B
$9.24M 2.94%
342,062
+196,186
XENE icon
11
Xenon Pharmaceuticals
XENE
$3.21B
$9.21M 2.94%
274,633
-101,212
DNLI icon
12
Denali Therapeutics
DNLI
$2.44B
$9.07M 2.89%
667,078
+82,750
CNTA
13
Centessa Pharmaceuticals
CNTA
$3.09B
$8.53M 2.72%
593,335
-48,629
QURE icon
14
uniQure
QURE
$3.57B
$7.75M 2.47%
731,039
+641,039
BBIO icon
15
BridgeBio Pharma
BBIO
$10.5B
$7.21M 2.3%
+208,437
CGON icon
16
CG Oncology
CGON
$3.16B
$7.1M 2.26%
+289,823
SWTX
17
DELISTED
SpringWorks Therapeutics
SWTX
$7.03M 2.24%
+159,305
ARQT icon
18
Arcutis Biotherapeutics
ARQT
$2.5B
$6.88M 2.19%
440,073
-60,893
INSM icon
19
Insmed
INSM
$35B
$6.64M 2.12%
87,059
-19,551
ALKS icon
20
Alkermes
ALKS
$5B
$6.35M 2.02%
192,352
-224,616
AKRO icon
21
Akero Therapeutics
AKRO
$4.32B
$6.32M 2.02%
+156,185
BHVN icon
22
Biohaven
BHVN
$1.69B
$6.02M 1.92%
250,564
+64,151
CYTK icon
23
Cytokinetics
CYTK
$6.99B
$6.01M 1.92%
149,648
+66,072
BPMC
24
DELISTED
Blueprint Medicines
BPMC
$5.48M 1.75%
+61,927
VTGN icon
25
VistaGen Therapeutics
VTGN
$124M
$5.11M 1.63%
2,366,554
+38,062